The role of interleukin 5 in asthma
- 3 May 2016
- journal article
- editorial
- Published by Taylor & Francis Ltd in Expert Review of Clinical Immunology
- Vol. 12 (9), 903-905
- https://doi.org/10.1080/1744666x.2016.1208564
Abstract
Eosinophils were first named in 1879 by Paul Ehrlich, who described their capacity to be stained by eosin, a bright red synthetic dye [1]. Ehrlich speculated correctly that cytoplasmic granules of ...Keywords
Funding Information
- Regione Campania CISI-Lab Project, CRèME Project, TIMING Project and ARMIA (Associazione Ricerca Malattie Allergiche e Immunologiche)
This publication has 29 references indexed in Scilit:
- Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the artAllergy, 2013
- Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): Clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group cohortArthritis & Rheumatism, 2012
- Increased production of IL-5 and dominant Th2-type response in airways of Churg–Strauss syndrome patientsRheumatology, 2012
- Asthma phenotypes: the evolution from clinical to molecular approachesNature Medicine, 2012
- Reslizumab for Poorly Controlled, Eosinophilic AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Molecular and clinical rationale for therapeutic targeting of interleukin‐5 and its receptorClinical & Experimental Allergy, 2011
- Eosinophils: multifaceted biological properties and roles in health and diseaseImmunological Reviews, 2011
- MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity functionJournal of Allergy and Clinical Immunology, 2010
- Mepolizumab and Exacerbations of Refractory Eosinophilic AsthmaThe New England Journal of Medicine, 2009
- Mepolizumab for Prednisone-Dependent Asthma with Sputum EosinophiliaThe New England Journal of Medicine, 2009